POSB50 A Cost-Effectiveness Analysis of Rivaroxaban in Combination with Acetylsalicylic Acid (ASA) in Adult Patients with Coronary Artery Disease (CAD) or Symptomatic Peripheral Artery Disease (PAD) at High Risk of Ischaemic Events
Pinheiro, B ; Gouveia, M ; Alarcão, J ; Ascenção, R ; Borges, M
Value in health, 2022-01, Vol.25 (1), p.S69-S69 [Periódico revisado por pares]Elsevier Inc
Texto completo disponível
Página Inicial
RSS
Feed
Políticas
Fale Conosco-
Realização:
Logos de Redes Sociais: 